• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Grifols

MedTech 100 roundup: Markets skid after strong stretch

June 15, 2020 By Sean Whooley

Following a strong performance over the last couple of weeks, the medtech market experienced one of its most significant drop-offs in recent months amid investor worries over a rise in COVID-19 cases in some states. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 82.12 points at […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, MassDevice Earnings Roundup, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: Abbott, Dow Jones, Grifols, Hologic, MedTech 100 Index, Moderna, Okami Medical, S&P, Senseonics

Grifols starts production of COVID-19 prevention drug

June 11, 2020 By Sean Whooley

Grifols (NSDQ:GRFS) announced today that it began production of its anti-SARS-CoV-2 hyperimmune immunoglobulin with specific antibodies for combating COVID-19. Barcelona-based Grifols touts the prevention drug, developed from the plasma of people who have overcome the disease, as the first specific drug developed to fight COVID-19, according to a news release. Get the full story at our sister […]

Filed Under: Business/Financial News, Pharmaceutical Tagged With: coronavirus, COVID-19, Grifols

J&J’s Ethicon wins clearance for devices to deliver Grifols surgical sealant

June 19, 2019 By Chris Newmarker

Johnson & Johnson’s Ethicon has won FDA clearance for airless spray devices to deliver Grifols’ fibrin sealant to stop surgical bleeding, the companies announced today. The Vistaseal fibrin sealant will be the first product Grifols (NSDQ:GRFS) is introducing with Johnson & Johnson (NYSE:JNJ) and Ethicon as part of a global partnership. Get the full story on our […]

Filed Under: 510(k), Business/Financial News, Drug-Device Combinations, Featured, Regulatory/Compliance, Surgical Tagged With: Ethicon, Grifols, Johnson and Johnson

FDA’s Gottlieb updates on IV bag shortages after Hurricane Maria

January 17, 2018 By Sarah Faulkner

FDA commissioner Dr. Scott Gottlieb expects that the shortage of IV fluids caused by Hurricane Maria in Puerto Rico will improve in the coming weeks and months, according to a statement issued by the agency yesterday. The regulatory chief said that the FDA is working with manufacturers like Baxter (NYSE:BAX) and B. Braun to import products from foreign facilities into the […]

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Pharmaceutical, Wall Street Beat Tagged With: B. Braun, Baxter, Fresenius, Grifols

Grifols wins FDA nod for fibrin sealant

November 6, 2017 By Fink Densford

Grifols (NSDQ:GRFS) said this week it won FDA approval for its Fibrin Sealant designed for surgical use in adults. The company said the newly cleared product is composed of the plasma proteins fibrinogen and human thrombin. Grifols said that the Fibrin Sealant will be manufactured at its Parts de Vallés facilities in Barcelona, Spain, according to an […]

Filed Under: Regulatory/Compliance, Surgical Tagged With: Grifols

Grifols posts Q3 sales, earnings gains

November 2, 2017 By Brad Perriello

Grifols (NSDQ:GRFS) today reported third-quarter sales and earnings growth that nevertheless missed the consensus forecast The Spanish healthcare giant posted profits of €153.9 million , or €0.22 per share, on sales of €1.06 billion for the three months ended Sept. 30 (about $179.3 million, 23¢ and $1.23 billion, respectively). Analysts on Wall Street were looking for earnings of 30¢ […]

Filed Under: MassDevice Earnings Roundup, Wall Street Beat Tagged With: Grifols

Hologic, Grifols close $2B Procleix blood-screening biz sale

February 1, 2017 By Sarah Faulkner

Hologic (NSDQ:HOLX) said today that it closed the sale of its stake in the Procleix blood-screening business it runs with Grifols (NSDQ:GRFS) for nearly $1.9 billion. Hologic, which makes the Procleix line, said it dealt its stake for $1.85 billion to Barcelona-based Grifols, which sells the molecular assays and instruments. Blood banks use the products to screen donated blood […]

Filed Under: Blood Management, Diagnostics, Mergers & Acquisitions, Wall Street Beat Tagged With: Grifols, Hologic, Seegene

Grifols pays $51m for minority stake in Access Biologicals

January 12, 2017 By Brad Perriello

Grifols (NSDQ:GRFS) said today that it paid $51 million for a 49% stake in Access Biologicals, in a deal that includes an option to acquire the rest of the business. That option, for the remaining 51% share in Vista, Calif.-based Access, goes live in 2022, Grifols said. The agreement also includes a provision to supply Access with non-human-use […]

Filed Under: Diagnostics, Mergers & Acquisitions, Pharmaceutical, Wall Street Beat Tagged With: Access Biologicals, Grifols

Hologic deals stake in Procleix blood-screening biz to Grifols for $1.9B

December 15, 2016 By Brad Perriello

Hologic (NSDQ:HOLX) said yesterday that it agreed to deal its stake in the Procleix blood-screening business it runs with  Grifols (NSDQ:GRFS) for nearly $1.9 billion. Hologic, which makes the Procleix line, said it’s selling its stake for $1.85 billion to Barcelona-based Grifols, which sells the molecular assays and instruments. Blood banks use the products to screen donated blood for […]

Filed Under: Blood Management, Mergers & Acquisitions, Wall Street Beat Tagged With: Grifols, Hologic

DoJ settles Grifols probe

October 11, 2016 By Fink Densford

The U.S. Justice Dept. closed its probe of Grifols (NSDQ:GRFS), according to an SEC filing from the company posted today. The DoJ told the company that it closed its investigation, which concerns “possible violations of the U.S. Foreign Corrupt Practices Act,” Sept. 29, according to the filing. Grifols wrote that in its decision to not prosecute, the DoJ acknowledged […]

Filed Under: Imaging, Legal News, Wall Street Beat Tagged With: Grifols, U.S. Justice Dept. (DOJ)

Grifols puts up $50m for 20% stake in Singulex

May 17, 2016 By Fink Densford

Grifols (NSDQ:GRFS) said today it invested $50 million in clinical diagnostic tech developer Singulex, giving Grifols a 20% stake in the company. Grifols’ investment in Singulex now has a fully-diluted pre-money valuation of $200 million, the company said in an SEC filing. Along with the investment, Grifols will be entitled to appoint a director to serve […]

Filed Under: Business/Financial News, Diagnostics Tagged With: Grifols, Singulex

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS